Self-reported adverse events associated with ∆8-Tetrahydrocannabinol (Delta-8-THC) Use
Abstract Background: There is an expanding unregulated market for a psychotropic compound called ∆8-Tetrahydrocannabinol (delta-8-THC) that is being derived from…
Igor Grant
Driving Performance and Cannabis Users’ Perception of Safety
Abstract This randomized clinical trial studies the magnitude and time course of effects of cannabis on driving, effect of cannabis…
HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Δ9-Tetrahydrocannabinol)-Induced Deficits
Abstract Background: HIV-associated neurocognitive disorder (HAND) is commonly observed in persons living with HIV (PWH) and is characterized by cognitive…
Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and blood
Abstract Objective: To determine whether cannabis may reduce HIV-related persistent inflammation, we evaluated the relationship of cannabis use in people…
A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain
Abstract Background: A recent meta-analysis affirmed the benefit of medicinal cannabis for chronic neuropathic pain, a disabling and difficult-to-treat condition.…
The Use of Cannabis for Headache Disorders
Abstract Headache disorders are common, debilitating, and, in many cases, inadequately managed by existing treatments. Although clinical trials of cannabis…
Medicinal Cannabis in California: An Interview with Igor Grant, MD
Abstract Dr. Igor Grant, MD, is distinguished professor and chair of psychiatry and director of the HIV Neurobehavioral Research Program…
Medical Marijuana: Clearing Away the Smoke
Abstract Recent advances in understanding of the mode of action of tetrahydrocannabinol and related cannabinoid in-gredients of marijuana, plus the…